Intuitive Surgical, Inc. $ISRG Shares Purchased by Checchi Capital Advisers LLC

Checchi Capital Advisers LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the 2nd quarter, Holdings Channel.com reports. The fund owned 3,044 shares of the medical equipment provider’s stock after acquiring an additional 68 shares during the period. Checchi Capital Advisers LLC’s holdings in Intuitive Surgical were worth $1,654,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. NBC Securities Inc. acquired a new stake in Intuitive Surgical in the 1st quarter valued at about $135,000. Vest Financial LLC raised its position in Intuitive Surgical by 73.5% in the 1st quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider’s stock valued at $2,342,000 after purchasing an additional 2,003 shares in the last quarter. Signal Advisors Wealth LLC raised its position in Intuitive Surgical by 12.9% in the 1st quarter. Signal Advisors Wealth LLC now owns 1,800 shares of the medical equipment provider’s stock valued at $891,000 after purchasing an additional 206 shares in the last quarter. Finally, SeaCrest Wealth Management LLC raised its position in Intuitive Surgical by 1.9% in the 1st quarter. SeaCrest Wealth Management LLC now owns 2,019 shares of the medical equipment provider’s stock valued at $1,000,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $452.35 on Friday. The stock has a fifty day moving average of $463.55 and a two-hundred day moving average of $500.06. The company has a market capitalization of $162.16 billion, a price-to-earnings ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ISRG shares. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Finally, Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $594.19.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.